Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]

Choosing wisely in complementary treatment for cancer in the Philippines

Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital...

Choosing wisely in complementary treatment for cancer in the Philippines ( Dr Ann Meredith Garcia-Trinidad - Dagupan Doctors Villaflor Memorial Hospital, Dagupan City, Philippines )

Indications for the appropriate use of a PET-CT scan for common cancers

Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines

Indications for the appropriate use of a PET-CT scan for common cancers ( Dr Jonas Santiago - St Luke's Medical Center, Manila, Philippines )

Choosing Wisely in neoadjuvant treatment for different cancers in the...

Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines

Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines ( Dr Priscilla Caguioa - St Luke's Medical Center, Manila, Philippines )

Tackling financial toxicity in Chile

Dr Nicolas Yanez - Clínica Alemana Valdivia, Valdivia, Chile

Tackling financial toxicity in Chile ( Dr Nicolas Yanez - Clínica Alemana Valdivia, Valdivia, Chile )

The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer

Dr Delia Guaqueta - Memorial Healthcare System, Miami, USA

The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer ( Dr Delia Guaqueta - Memorial Healthcare System, Miami, USA )

Current indications and challenges with IORT in the Philippines

Dr Henri Cartier Co - Philippine General Hospital, Manila, Philippines

Current indications and challenges with IORT in the Philippines ( Dr Henri Cartier Co - Philippine General Hospital, Manila, Philippines )

Choosing the right serum and molecular biomarkers in the Philippines

Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines

Choosing the right serum and molecular biomarkers in the Philippines ( Dr Jose Jasper Andal - St Luke's Medical Center, Manila, Philippines )

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR...

Prof Nicolas Girard - Institut Curie, Paris, France

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical...

Prof Nicolas Girard - Institut Curie, Paris, France

Neoadjuvant nivolumab plus chemotherapy continues to provide long-term clinical benefit in patients with resectable NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

Four chemo cycles given with durvalumab and tremelimumab optimise response and...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

LUMINANCE: Results support use of durvalumab and platinum-etoposide for...

Dr Niels Reinmuth - University of Muenster, Gauting, Germany

LUMINANCE: Results support use of durvalumab and platinum-etoposide for extensive stage SCLC ( Dr Niels Reinmuth - University of Muenster, Gauting, Germany )

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for...

Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC ( Dr David Waterhouse - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer